Inventor
VAN DEN KEYBUS FRANS ALFONS MARIA
BE12 patents
⚠️ This page may combine multiple inventors who share the name “VAN DEN KEYBUS FRANS ALFONS MARIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
7 patentsUS9468640B2Oct 18, 2016
Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
JANSSEN PHARMACEUTICA NV1 citations61
US9751860B2Sep 5, 2017
Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
JANSSEN PHARMACEUTICA NV0 citations50
US11319321B2May 3, 2022
[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors
JANSSEN PHARMACEUTICA NV0 citations48
US10947242B2Mar 16, 2021
[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors
JANSSEN PHARMACEUTICA NV0 citations46
US10112943B2Oct 30, 2018
Substituted imidazoles as gamma secretase modulators
JANSSEN PHARMACEUTICA NV0 citations39
US10562897B2Feb 18, 2020
Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
JANSSEN PHARMACEUTICA NV0 citations37
US10246454B2Apr 2, 2019
Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators
JANSSEN PHARMACEUTICA NV0 citations37
MACDONALD GREGOR JAMES
3 patentsUS8778974B2Jul 15, 2014
Trisubstituted 1,2,4 triazoles
MACDONALD GREGOR JAMES2 citations57
US8791144B2Jul 29, 2014
Substituted N-phenyl-1-(4-Pyridinyl)-1H-pyrazol-3-amines
MACDONALD GREGOR JAMES0 citations50
US8466153B2Jun 18, 2013
Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
MACDONALD GREGOR JAMES0 citations50